Paul Kaye

Accepting PhD Students

If you made any changes in Pure these will be visible here soon.

Paul is a member of the Experimental Medicine and Biomedicine research group at Hull York Medical School.

Down-regulation of MALAT1 is a hallmark of tissue and peripheral proliferative T cells in COVID-19
Dey, S., Ashwin, H., Milross, L., Hunter, B., Majo, J., Filby, A. J., Fisher, A. J., Kaye, P. & Lagos, D., 3 Mar 2023, (E-pub ahead of print) In: Clinical and Experimental Immunology.
Research output: Contribution to journal › Article › peer-review

Open Access
Identification of a protein expression signature distinguishing early from organising diffuse alveolar damage in COVID-19 patients
Ashwin, H., Milross, L., Wilson, J., Majo, J., Hang Lee, J. T., Calder, G., Hunter, B., James, S., Lagos, D., Signoret, N., Filby, A., Bayraktar, O. A., Fisher, A. J. & Kaye, P. M., 9 Mar 2023, (E-pub ahead of print) In: Journal of clinical pathology. 5 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
Corrigendum: miR-548d-3p Is Up-regulated in Human Visceral Leishmaniasis and Suppresses Parasite Growth in Macrophages
Ramos-Sanchez, E. M., Reis, L. C., Souza, M. D. A., Muxel, S. M., Santos, K. R., Lagos, D., Pereira, V. R. A., de Brito, M. E. F., Kaye, P. M., Floeter-Winter, L. M. & Goto, H., 16 Mar 2022, In: Frontiers in cellular and infection microbiology. 12, 1 p., 876035.
Research output: Contribution to journal › Article › peer-review

Open Access
File

Paul Kaye, PhD FRCPath FMedSci